Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.51M P/E 0.01 EPS this Y 90.10% Ern Qtrly Grth -
Income -15.91M Forward P/E -0.34 EPS next Y 91.60% 50D Avg Chg -62.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -86.00%
Dividend N/A Price/Book 0.30 EPS next 5Y - 52W High Chg -99.00%
Recommedations 2.50 Quick Ratio 1.33 Shares Outstanding 1.97M 52W Low Chg 8.00%
Insider Own 6.94% ROA -165.01% Shares Float 648.59K Beta 1.29
Inst Own 4.18% ROE -3,139.91% Shares Shorted/Prior 13.85K/35.39K Price 0.52
Gross Margin - Profit Margin - Avg. Volume 1,801,430 Target Price 36.00
Oper. Margin - Earnings Date Mar 29 Volume 216,676 Change 0.19%
About First Wave BioPharma, Inc.

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients; and niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties. The company develops FW-COV, which is in Phase II clinical trials for the treatment of severe acute respiratory syndrome coronavirus 2 gastrointestinal infections; FW-UP, which is in Phase II clinical trials for the treatment ulcerative proctitis and ulcerative proctosigmoiditis; FW-ICI-AC for immune checkpoint inhibitor-associated colitis and diarrhea in advanced stage oncology patients; and FW-UC, which is in Phase Ib/IIa clinical trials for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis. It also develops FW-CD, which has completed Phase I clinical trials for Crohn's disease; and adrulipase, an oral, non-systemic, and biologic capsule for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis. The company was formerly known as AzurRx BioPharma, Inc. and changed its name to First Wave BioPharma, Inc. in September 2021. First Wave BioPharma, Inc. was incorporated in 2014 and is headquartered in Boca Raton, Florida.

First Wave BioPharma, Inc. News
03/18/24 First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
03/14/24 First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
03/05/24 First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference
03/04/24 First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering
02/13/24 First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
01/23/24 First Wave BioPharma to Present at the DealFlow MicroCap Conference
01/17/24 First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
01/04/24 First Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024
12/27/23 First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds Priced
12/27/23 First Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD Program
12/18/23 First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company
12/14/23 First Wave BioPharma Announces 1-for-20 Reverse Stock Split and Results of the Special Meeting of Stockholders
12/06/23 First Wave BioPharma to Participate in BIO Partnering @JPM During “J.P. Morgan Week 2024”
12/05/23 First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Conference
10/10/23 Date and Time Announced for First Wave BioPharma CEO James Sapirstein’s Presentation at the 2023 BIO Investor Forum
10/03/23 First Wave BioPharma CEO James Sapirstein to Present at the 2023 Roth Healthcare Opportunities Conference
09/15/23 First Wave BioPharma To Present at the BIO Investor Forum
09/14/23 First Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.0 Million Gross Proceeds Priced At-the-Market
09/14/23 First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
09/05/23 First Wave BioPharma to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
FWBI Chatroom

User Image 2moroisanewday Posted - 7 hours ago

$FWBI Well it’s about time

User Image RollingDollar Posted - 12 hours ago

$FWBI

User Image RollingDollar Posted - 12 hours ago

$FWBI

User Image RollingDollar Posted - 13 hours ago

$FWBI

User Image RollingDollar Posted - 13 hours ago

$FWBI

User Image Bronco6970 Posted - 17 hours ago

$FWBI what happened to $40???

User Image SaccaSpuds Posted - 1 day ago

$FWBI going

User Image TraderJackson_ Posted - 1 day ago

TTNP Top Squeeze Watch! Keep it on watch for another high volume spike to 12+ $FLJ $FOXO $FRGT $FWBI 00

User Image TraderJackson_ Posted - 1 day ago

$NURO $HOLO $GETY $FWBI BREAKING OUT 🍊

User Image happydaysss Posted - 2 days ago

$FWBI cheap cheap cheap

User Image ShamUS1 Posted - 2 days ago

$FWBI First Wave Bio Scam

User Image FlyingAces Posted - 3 days ago

$FWBI wow, just wow 👌

User Image showtiime Posted - 3 days ago

$FWBI Broke channel I don’t like it

User Image ShamUS1 Posted - 3 days ago

$FWBI

User Image hartman2022 Posted - 3 days ago

$FWBI earnings today?

User Image paivante69 Posted - 5 days ago

$FWBI no comments

User Image paivante69 Posted - 5 days ago

$FWBI

User Image paivante69 Posted - 5 days ago

$FWBI outstanding action 1 974 744 the usual lie

User Image SaccaSpuds Posted - 6 days ago

$FWBI shot stop going sub $1

User Image poointhepants Posted - 1 week ago

$FWBI this is a pump and dump and a smelly stock

User Image showtiime Posted - 1 week ago

$FWBI Boys stop playing

User Image showtiime Posted - 1 week ago

$FWBI This is where you stand

User Image showtiime Posted - 1 week ago

$FWBI Adding

User Image Davetopgun Posted - 1 week ago

$FWBI OCGN party ready ...10 plus...join party

User Image happydaysss Posted - 1 week ago

$FWBI buying every day up or down

User Image happydaysss Posted - 1 week ago

$FWBI keep pushing down down down. Sleeping giant. Worth £25

User Image showtiime Posted - 1 week ago

$FWBI 1/4 of position here waiting for more signals

User Image showtiime Posted - 1 week ago

$FWBI Close above 5.70 we got something until then I don’t like it

User Image BusyMind Posted - 1 week ago

$GNS Can it because of All Shares Merge news that hit yesterday ? $FWBI dropped %50 after that news due to people thought there will be huge dilluiting. Maybe we are looking blinded as we are holding but this sells reason Can be this and if it is we are all f... :)

User Image showtiime Posted - 1 week ago

$FWBI Hello

Analyst Ratings
Roth MKM Buy Mar 15, 24
Roth MKM Buy Jan 3, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Romano Sarah Chief Financial Offi.. Chief Financial Officer Jan 12 Sell 4.20 98 412 20,306 01/17/24
SAPIRSTEIN JAMES Chairman, President.. Chairman, President and CEO Jan 12 Sell 4.20 166 697 39,166 01/17/24
CASAMENTO CHARLES J Director Director Sep 15 Sell 0.43 10 4 6,098 09/18/23
CASAMENTO CHARLES J Director Director Aug 31 Sell 0.30 6,053 1,816 6,108 09/05/23